Reply to letter to editor by Hadigal et al. regarding the immunogenicity and safety trial of high-dose influenza vaccine in adults aged ≥60 years

Hadigal et al. argued the recommendation of high-dose influenza vaccine over standard-dose formulation is not supported by comparisons of numbers-needed-to-vaccinate (NNV) nor aligned with the WHO mandate of improving vaccine coverage. However, the authors’ NNV calculation was inaccurate. A preferen...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, J. Kevin, Pepin, Stephanie, van Aalst, Robertus, Loiacono, Matthew M., Samson, Sandrine I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Influenza – Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750711/
https://www.ncbi.nlm.nih.gov/pubmed/35914122
http://dx.doi.org/10.1080/21645515.2022.2106749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750711/
https://www.ncbi.nlm.nih.gov/pubmed/35914122
http://dx.doi.org/10.1080/21645515.2022.2106749

Ejemplares similares